Racial Disparities Seen for Cost of Unplanned Care After Breast Reconstruction
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Aug. 2, 2023 -- While race is not a significant predictor of unplanned hospital visits after breast reconstruction surgery, racial minorities bear a higher cost burden than White breast reconstruction patients, according to a study published online in the August issue of Plastic and Reconstructive Surgery.
Jacob S. Nasser, from George Washington University in Washington, D.C., and colleagues examined the effect of race on the rate and cost of unplanned hospitalizations after breast reconstruction procedures. The analysis included 17,042 patients.
The researchers found that the overall rate of an unplanned visit was 5 percent. While the rates of readmissions were higher among Black patients (6 percent) and Hispanic patients (7 percent) versus White patients (5 percent), race was not an independent predictor of an unplanned visit when controlling for patient-level characteristics. However, expenditure was significantly higher for Black patients (adjusted cost ratio, 1.35) and Hispanic patients (adjusted cost ratio, 1.34) versus White patients.
"Adjusted payment models may be a strategy to reduce disparities in surgical care," the authors write. "In addition, direct and indirect measures of disparities should be used when examining health care disparities to identify consequences of inequities more robustly."
One author reported receiving book royalties from Wolters Kluwer and Elsevier.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
Few Patients With Positive Margins After Basal Cell Excision Have Recurrence
MONDAY, July 1, 2024 -- Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence...
NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians
FRIDAY, June 28, 2024 -- Almost 90 percent of medical centers report cancer drug shortages, which often impact clinical trials, according to the results of a National...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.